Rocket One RKTO
NASDAQ RKTO
$0.67 -0.03 (-4.40%)
At close: Sep 9, 2026 · 4:00 PM EDT

Rocket One (RKTO) Cash from Financing Activities (2018 - 2026)

Rocket One's (RKTO) quarterly Cash from Financing Activities came in at $6.8 million in Q2 2026, up 10209.42% year-over-year from N/an in Q2 2025, and up 871.46% quarter-over-quarter from $701484.0 in Q1 2026.

Analysis

Rocket One (RKTO) Cash from Financing Activities (2018 - 2026) Analysis & Trends

Rocket One has disclosed Cash from Financing Activities across 9 years of filings, most recently posting $6.8 million for Q2 2026.

  • In Q2 2026, Cash from Financing Activities rose 10209.42% year-over-year to $6.8 million; the TTM figure through Jun 2026 stood at $9.7 million (up 18.31% YoY), while the FY2025 annual figure was $9.3 million, up 96.3% from the prior year.
  • Cash from Financing Activities came in at $6.8 million for Q2 2026 at Rocket One, up from $701484.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $8.9 million in Q1 2023 to a low of $50990.0 in Q4 2022.
  • Average Cash from Financing Activities over 5 years is $2.9 million, with a median of $1.3 million recorded in 2024.
  • The largest YoY upside for Cash from Financing Activities was 10209.42% in 2026 against a maximum downside of 90.07% in 2026.
  • Over 5 years, Cash from Financing Activities stood at $50990.0 in 2022, then surged by 4618.5% to $2.4 million in 2023, then sank by 55.91% to $1.1 million in 2024, then plunged by 48.14% to $550138.0 in 2025, then jumped by 1138.71% to $6.8 million in 2026.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were $6.8 million in Q2 2026, $701484.0 in Q1 2026, and $550138.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn -1.48 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 2.34 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -426.70 Mn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn -1.22 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 14.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 36.24 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 1.30 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -181.51 Mn
10 Rocket One 13.86 Mn 5.97 Mn - 6.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.81 Mn
Mar 31, 2026 701,484.00
Dec 31, 2025 550,138.00
Sep 30, 2025 1.63 Mn
Jun 30, 2025 66,101.00
Mar 31, 2025 7.07 Mn
Dec 31, 2024 1.06 Mn
Sep 30, 2023 2.41 Mn
Mar 31, 2023 8.91 Mn
Dec 31, 2022 50,990.00
Sep 30, 2021 -100,000.00
Jun 30, 2021 -136,732.00
Mar 31, 2021 18.43 Mn
Jun 30, 2020 4.49 Mn
Mar 31, 2020 4.23 Mn
Sep 30, 2019 1.61 Mn
Jun 30, 2019 -17,169.00
Mar 31, 2019 5.86 Mn
Sep 30, 2018 -31,514.00
Mar 31, 2018 1.19 Mn